Exit Notice
You are about to leave ClinicalTrials.gov and go to: Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial URL: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31604-4/fulltext
Click on the link to continue or return to ClinicalTrials.gov Home